BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 20575634)

  • 1. Methylene blue for the treatment of septic shock.
    Paciullo CA; McMahon Horner D; Hatton KW; Flynn JD
    Pharmacotherapy; 2010 Jul; 30(7):702-15. PubMed ID: 20575634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of the nitric oxide pathway in refractory septic shock].
    Andresen M; Dougnac A; Hernández G; Espejo J; Castillo L; Bugedo G; Letelier LM; Dagnino J
    Rev Med Chil; 1996 Apr; 124(4):442-7. PubMed ID: 9110484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue administration in septic shock: a clinical trial.
    Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
    Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.
    Weingartner R; Oliveira E; Oliveira ES; Sant'Anna UL; Oliveira RP; Azambuja LA; Friedman G
    Braz J Med Biol Res; 1999 Dec; 32(12):1505-13. PubMed ID: 10585632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged methylene blue infusion in refractory septic shock: a case report.
    Dumbarton TC; Minor S; Yeung CK; Green R
    Can J Anaesth; 2011 Apr; 58(4):401-5. PubMed ID: 21246318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.
    Juffermans NP; Vervloet MG; Daemen-Gubbels CR; Binnekade JM; de Jong M; Groeneveld AB
    Nitric Oxide; 2010 May; 22(4):275-80. PubMed ID: 20109575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene blue increases myocardial function in septic shock.
    Daemen-Gubbels CR; Groeneveld PH; Groeneveld AB; van Kamp GJ; Bronsveld W; Thijs LG
    Crit Care Med; 1995 Aug; 23(8):1363-70. PubMed ID: 7634806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terlipressin: vasopressin analog and novel drug for septic shock.
    Pesaturo AB; Jennings HR; Voils SA
    Ann Pharmacother; 2006 Dec; 40(12):2170-7. PubMed ID: 17148649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of methylene blue in sepsis: a systematic review.
    Kwok ES; Howes D
    J Intensive Care Med; 2006; 21(6):359-63. PubMed ID: 17095500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration.
    Mount JC; Rowe AS
    Pharmacotherapy; 2010 Mar; 30(3):323. PubMed ID: 20180614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?
    Donati A; Conti G; Loggi S; Münch C; Coltrinari R; Pelaia P; Pietropaoli P; Preiser JC
    Crit Care Med; 2002 Oct; 30(10):2271-7. PubMed ID: 12394955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.
    Gachot B; Bedos JP; Veber B; Wolff M; Regnier B
    Intensive Care Med; 1995 Dec; 21(12):1027-31. PubMed ID: 8750129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue.
    Evora PR; Simon MR
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):306-13. PubMed ID: 17941276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.
    Zhang H; Rogiers P; Preiser JC; Spapen H; Manikis P; Metz G; Vincent JL
    Crit Care Med; 1995 Oct; 23(10):1711-21. PubMed ID: 7587237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of methylene blue in human septic shock: renaissance of an old drug?
    Evgenov OV; Bjertnaes LJ
    Crit Care Med; 2003 May; 31(5):1601-2; author reply 1602. PubMed ID: 12771654
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
    Park BK; Shim TS; Lim CM; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
    Korean J Intern Med; 2005 Jun; 20(2):123-8. PubMed ID: 16134766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of methylene blue infusion on gastric tonometry and intestinal fatty acid binding protein levels in septic shock patients.
    van Haren FM; Pickkers P; Foudraine N; Heemskerk S; Sleigh J; van der Hoeven JG
    J Crit Care; 2010 Jun; 25(2):358.e1-7. PubMed ID: 20381302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene Blue: Magic Bullet for Vasoplegia?
    Hosseinian L; Weiner M; Levin MA; Fischer GW
    Anesth Analg; 2016 Jan; 122(1):194-201. PubMed ID: 26678471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange.
    Andresen M; Dougnac A; Díaz O; Hernández G; Castillo L; Bugedo G; Alvarez M; Dagnino J
    J Crit Care; 1998 Dec; 13(4):164-8. PubMed ID: 9869542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.